A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT01965509
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 120 participants
- Registry
-
NCT01965509
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01965509. Randomized; quadruple masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2013-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- PEX168 or placebo
- Lead sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Collaborator
- China-Japan Friendship Hospital
Record details
- Record id
cardio:ct-nct01965509- Content hash
cf937c5737028b610cef703c55aba03cf4838a5382cd3b8f8885c85e6888da50